Duygu Baylam Geleri

Duygu Baylam Geleri

Auto-generated profile, based on publicly available information

Duygu Baylam Geleri

Department of Radiology (D.B.G, B.C., C.Y.), University of Washington, Seattle, WA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
DGDuygu Baylam Geleri
Duygu Baylam Geleri
HWHiroko Watase
Hiroko Watase
BCBaocheng Chu
Baocheng Chu
LCLi Chen
Li Chen
Huilin ZhaoHuilin Zhao
Huilin Zhao
OCon behalf of the CARE-II Study Collaborators
on behalf of the CARE-II Study Collaborators
Background and Purpose: Two-dimensional high-resolution multicontrast magnetic resonance imaging (2D-MC MRI) is currently the most reliable and reproducible noninvasive carotid vessel wall imaging technique. However, the long scan time required for 2D-MC MRI restricts its practical clinical application. Alternatively, 3-dimensional motion-sensitized driven-equilibrium prepared rapid gradient echo (3D-MERGE) vessel wall MRI can provide high isotropic resolution with extensive coverage in two minutes. In this study, we sought to prove that 3D-MERGE alone can serve as a screening tool to identify advanced carotid lesions. Methods: Two hundred twenty-seven subjects suspected of recent ischemic stroke or transient ischemic attack were imaged using 2D-MC MRI with an imaging time of 30 minutes, then with 3D-MERGE with an imaging time of 2 minutes, on 3T-MRI scanners. Two experienced reviewers interpreted plaque components using 2D-MC MRI as the reference standard and categorized plaques using a modified American Heart Association lesion classification for MRI. Plaques of American Heart Association type IV and above were classified as advanced. Arteries of American Heart Association types I to II and III were categorized as normal or with early lesions, respectively. One radiologist independently reviewed only 3D-MERGE and labeled the plaques as advanced if they had a wall thickness of >2 mm with high or low signal intensity compared with the adjacent sternocleidomastoid muscle. Sensitivity, specificity, and accuracy for 3D-MERGE were calculated. Results: Four hundred forty-nine arteries from 227 participants (mean age 61.2 years old, 64% male) were included in the analysis. Sensitivity, specificity, and accuracy for identification of advanced lesions on 3D-MERGE were 95.0% (95% CI, 91.8–97.2), 86.9% (95% CI, 81.4–92.0), 93.8% (95% CI, 91.1–95.8), respectively. Conclusions: 3D-MERGE can accurately identify advanced carotid atherosclerotic plaques in patients suspected of stroke or transient ischemic attack. It has a more extensive coverage and higher sensitivity and specificity for advanced plaque detection with a much shorter acquisition time than 2D-MC MRI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02017756.